STAAR Surgical (STAA) Form 144 Notice — 13,491-Share Sale

Rhea-AI Filing Summary

Form 144 Filing Summary for STAAR Surgical Co (STAA)

The filer reports a proposed sale of 13,491 common shares with an aggregate market value of $362,523.41, with an approximate sale date of 08/05/2025 on NASDAQ. Total shares outstanding are listed as 49,526,129. Broker: Merrill Lynch, 520 Newport Center Drive, Floor 20, Newport Beach, CA.

Acquisition details provided: 2,000 shares acquired via open market purchase on 08/07/2023 (cash paid 08/09/2023); 3,417 shares from RSU vesting on 06/15/2024; 8,074 shares from RSU vesting on 06/18/2025. The filer reports Nothing to Report for securities sold during the past three months.

Insights

Financial Analyst

TL;DR: Routine Rule 144 notice showing proposed sale of 13,491 shares and source of holdings.

The filing is a standard Form 144 notification disclosing a proposed sale of 13,491 common shares valued at $362,523.41, to be executed approximately on 08/05/2025 on NASDAQ. The document lists the broker (Merrill Lynch) and breaks down acquisition sources: an open-market purchase of 2,000 shares (08/07/2023, cash paid 08/09/2023) and RSU vesting events totaling 11,491 shares in 2024–2025. No sales in the prior three months are reported. This provides clear, transaction-level disclosure for market participants.

Corporate Governance Expert

TL;DR: Filing appears to meet Rule 144 disclosure requirements with acquisition and broker details included.

The notice identifies the class of security, broker, aggregate market value, approximate sale date, and detailed acquisition history (open-market purchase and RSU vesting dates and amounts). The form also explicitly states there were no securities sold in the past three months. These elements align with the standard data points required for a Rule 144 notice and permit verification of holding sources and timing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 520 Newport Center Drive Floor 20 Newport Beach CA 92660	13491	362523.41	49526129	08/05/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/07/2023	Open Market Purchase	N/A			2000	08/09/2023	Cash
Common	06/15/2024	Restricted Stock Unit Vest	STAAR Surgical Company			3417	06/15/2024	N/A
Common	06/18/2025	Restricted Stock Unit Vest	STAAR Surgical Company			8074	06/18/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the STAA Form 144 disclose?

The Form 144 discloses a proposed sale of 13,491 common shares of STAAR Surgical (STAA) valued at $362,523.41, with an approximate sale date of 08/05/2025 on NASDAQ.

How many shares and what value are proposed for sale in the Form 144?

The filing lists 13,491 shares with an aggregate market value of $362,523.41.

What are the acquisition sources and dates for the shares to be sold?

Acquisitions: 2,000 open-market purchase on 08/07/2023 (cash paid 08/09/2023); 3,417 RSU vest on 06/15/2024; 8,074 RSU vest on 06/18/2025.

Which broker is handling the proposed sale?

The broker listed is Merrill Lynch, 520 Newport Center Drive, Floor 20, Newport Beach, CA.

Did the filer report any securities sold in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months.